Reining in impulsivity

Up to 20 percent of people with Parkinson’s disease who take a new class of drugs to help reduce their stiffness, shakiness, slowness or unsteadiness have encountered an unwanted side-effect: impulsivity. Although the drugs, ropinirole and pramipexole, are effective at reducing motor control problems, the unwanted impulsivity can lead people into destructive behaviours. At the … Read more

November is “Make A Will Month”—Do you have one?

It’s never too early to start estate planning. And you should update your Will after any major life event, such as a birth, divorce, death or change to your financial status. Without proper estate planning, you will not be able to influence how, when, and to whom your assets will be distributed after you pass. … Read more

Lows in Motion 2018—not your typical fundraiser; it’s a unique and energetic “Shaker”—pun intended.

This annual event provides an opportunity for community members to unite in the fight against Parkinson’s disease, with all funds raised going to Parkinson Canada, the definitive voice of the over 100,000 Canadians living with Parkinson’s today. On Saturday, November 3rd, the Lows in Motion organizing committee welcomed yet another sellout crowd to Saskatoon’s Prairieland … Read more

Parkinson Canada researchers aim for early diagnosis

Whether they are established experts, or just beginning their careers, Parkinson’s researchers count on funding from the Parkinson Canada Research Program to test new theories and to discover a critical piece of the complex puzzle that is Parkinson’s disease. Currently, there is no cure for Parkinson’s disease. If researchers could find a non-invasive, physiological tool … Read more

Gaining a new perspective on an old problem

Topographical analysis of the trajectory of dopaminergic degeneration in symptomatic and pre-manifest Parkinson’s. Dr. Michele Matarazzo, a neurologist with the Pacific Parkinson’s Research Centre at the University of British Columbia, is assembling a database of brain imaging scans to show the progression of Parkinson’s disease in patients over the course of several years. This information, provided … Read more

Understanding where to hit Parkinson’s disease

Novel, tissue-specific, inducible, adult-onset reversible animal models for the role of mitochondria in Parkinson’s disease Using specially designed, genetically altered mice, McGill University postdoctoral researcher Ying Wang is demonstrating what type of age-dependent decline of nerve cell function could cause Parkinson’s disease. By inducing Parkinson’s and then using a drug to reverse the disease in … Read more

Your gift of stock offers tax benefits and supports Parkinson Canada

A donation of publicly traded stock or securities is the most effective way you can support Parkinson Canada. These types of gifts are a win-win opportunity for donors because they eliminate capital gains taxes and at the same time support Parkinson Canada with an influx of capital that can be used to increase funding for … Read more

Duodopa Receives Positive Recommendation

Parkinson Canada is pleased to let you know that a positive recommendation has been published from Canadian Agency for Drugs and Technologies in Health (CADTH’s) Canadian Drug Expert Committee (CDEC) to reimburse DUODOPA for advanced Parkinson’s patients when oral medications no longer control symptoms. As you may know, Duodopa previously had a negative recommendation from … Read more